We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

175 hedge funds and large institutions have $439M invested in Filana Therapeutics in 2022 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 44 increasing their positions, 34 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 23

60% more call options, than puts

Call options by funds: $276M | Put options by funds: $173M

57% more capital invested

Capital invested by funds: $279M → $439M (+$160M)

29% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 34

17% more funds holding

Funds holding: 149 → 175 (+26)

1.34% more ownership

Funds ownership: 24.89% → 26.23% (+1.3%)

Holders
175
Holders Change
+26
Holders Change %
+17.45%
% of All Funds
3.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
49
Increased
44
Reduced
34
Closed
23
Calls
$276M
Puts
$173M
Net Calls
+$103M
Net Calls Change
+$106M

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$6.49M
2
Marshall Wace
Marshall Wace
United Kingdom
+$4.25M
3
Bank of America
Bank of America
North Carolina
+$3.34M
4
GC
GMT Capital
Georgia
+$3.11M
5
SC
Sculptor Capital
New York
+$2.04M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$4.75M
2
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$2.49M
3
Stifel Financial
Stifel Financial
Missouri
-$2.45M
4
SG Americas Securities
SG Americas Securities
New York
-$1.25M
5
KAS
Kestra Advisory Services
Texas
-$984K
Name Holding Trade Value Shares
Change 		Change in
Stake
HNWAG
151
High Net Worth Advisory Group
Florida
$8K +$5.4K +200 New
HI
152
Harbour Investments
Wisconsin
$7K – – –
BFEC
153
Benjamin F. Edwards & Company
Missouri
$6K – – –
CFD
154
Creative Financial Designs
Indiana
$6K – – –
S
155
SignatureFD
Georgia
$6K +$1.97K +73 +101%
IA
156
IFP Advisors
Florida
$4K – – –
LWCFA
157
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$4K – – –
RMC
158
Resources Management Corp
Connecticut
$4K – – –
HPC
159
HM Payson & Co
Maine
$4K +$675 +25 +35%
QT
160
Quantbot Technologies
New York
$4K +$2.7K +100 New
FCMT
161
Founders Capital Management (Texas)
Texas
$3K – – –
SPIA
162
Steward Partners Investment Advisory
New York
$3K – – –
WFA
163
Wipfli Financial Advisors
Wisconsin
$3K +$1.62K +60 New
BWM
164
BerganKDV Wealth Management
Minnesota
$2K – – –
SSB
165
Sandy Spring Bank
Maryland
$2K – – –
LFG
166
Larson Financial Group
Missouri
$2K +$1.05K +39 New
CWA
167
Carolina Wealth Advisors
South Carolina
$2K +$1.3K +48 New
SWM
168
Spire Wealth Management
Virginia
$1K – – –
MOS
169
MGO One Seven
Ohio
$227 +$147K +5,432 New
Stifel Financial
170
Stifel Financial
Missouri
– -$2.45M -87,175 Closed
KAS
171
Kestra Advisory Services
Texas
– -$984K -34,997 Closed
GC
172
Guggenheim Capital
Illinois
– -$839K -29,808 Closed
Group One Trading
173
Group One Trading
Illinois
– -$640K -23,682 Closed
LIM
174
Leavell Investment Management
Alabama
– -$315K -11,200 Closed
IMC Chicago
175
IMC Chicago
Illinois
– -$274K -10,132 Closed
4 5 6
7
8

FLNA Hedge Fund Activity: Q3 2022 in Review

175 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2022, worth a combined $439M — up 57% from $279M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new FLNA positions and 23 closed out — a net gain of 26 holders — while 44 added to existing stakes and 34 trimmed.

The largest buyer was Invesco, adding an estimated $6.49M. The largest seller was BlackRock, cutting an estimated $4.75M.

  • 175 institutional investors held Filana Therapeutics (FLNA) as of Q3 2022, up from 149 in Q2 2022.
  • Funds reported $439M of Filana Therapeutics stock for Q3 2022, up 57% quarter-over-quarter.
  • 49 funds opened new Filana Therapeutics positions in Q3 2022 and 23 closed out, a net change of +26 holders.
  • The largest Filana Therapeutics buyer in Q3 2022 was Invesco, an estimated $6.49M added.
  • The largest Filana Therapeutics seller in Q3 2022 was BlackRock, an estimated $4.75M sold.

Based on aggregated 13F filings for Q3 2022.